4//SEC Filing
Prince Joshua S. 4
Accession 0001415889-25-001402
CIK 0001411685other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:40 PM ET
Size
5.1 KB
Accession
0001415889-25-001402
Insider Transaction Report
Form 4
Prince Joshua S.
Chief Operating Officer
Transactions
- Award
Common Stock
2024-12-31$2.51/sh+3,310$8,300→ 5,981 total
Footnotes (1)
- [F1]The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).
Documents
Issuer
Vistagen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001998663
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:40 PM ET
- Size
- 5.1 KB